Last updated: 21 June 2024 at 4:06pm EST

Mark Currie Net Worth




The estimated Net Worth of Mark G Currie is at least $12.8 Milione dollars as of 11 August 2022. Mark Currie owns over 70,000 units of Ironwood Pharmaceuticals Inc stock worth over $2,269,647 and over the last 15 years he sold IRWD stock worth over $6,349,355. In addition, he makes $4,132,130 as Director at Ironwood Pharmaceuticals Inc.

Mark Currie IRWD stock SEC Form 4 insiders trading

Mark has made over 36 trades of the Ironwood Pharmaceuticals Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 70,000 units of IRWD stock worth $824,600 on 11 August 2022.

The largest trade he's ever made was exercising 300,000 units of Ironwood Pharmaceuticals Inc stock on 31 October 2016 worth over $882,000. On average, Mark trades about 43,839 units every 70 days since 2010. As of 11 August 2022 he still owns at least 521,758 units of Ironwood Pharmaceuticals Inc stock.

You can see the complete history of Mark Currie stock trades at the bottom of the page.





Mark Currie biography

Dr. Mark G. Currie, Ph.D. is Director of the Company. Dr. Currie has served as president and chief scientific officer of Cyclerion Therapeutics, Inc. since April 2019, and previously served as senior vice president, chief scientific officer and president of R&D at Ironwood Pharmaceuticals, Inc. from 2002 to April 2019.Prior to joining Ironwood, Dr. Currie directed cardiovascular and central nervous system disease research as vice president of discovery research at Sepracor, Inc. Previously, Dr. Currie initiated, built and led discovery pharmacology and also served as director of arthritis and inflammation at Monsanto Company. Dr. Currie earned a B.S. in biology from the University of South Alabama and holds a Ph.D. in cell biology from the Bowman-Gray School of Medicine of Wake Forest University. Currie's vast experience leading the research and development efforts of an international biotechnology company will prove instrumental in guiding us through the research and development of novel therapie

What is the salary of Mark Currie?

As the Director of Ironwood Pharmaceuticals Inc, the total compensation of Mark Currie at Ironwood Pharmaceuticals Inc is $4,132,130. There are 2 executives at Ironwood Pharmaceuticals Inc getting paid more, with Mark Mallon having the highest compensation of $10,068,800.



How old is Mark Currie?

Mark Currie is 65, he's been the Director of Ironwood Pharmaceuticals Inc since 2019. There are 2 older and 17 younger executives at Ironwood Pharmaceuticals Inc. The oldest executive at Ironwood Pharmaceuticals Inc is Edward Owens, 73, who is the Independent Director.

What's Mark Currie's mailing address?

Mark's mailing address filed with the SEC is C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110.

Insiders trading at Ironwood Pharmaceuticals Inc

Over the last 15 years, insiders at Ironwood Pharmaceuticals Inc have traded over $83,928,361 worth of Ironwood Pharmaceuticals Inc stock and bought 2,478,676 units worth $24,100,589 . The most active insiders traders include Llc Fmr, Bryan E Roberts e Alexander J Denner. On average, Ironwood Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $239,611. The most recent stock trade was executed by Minardo John on 12 August 2024, trading 9,910 units of IRWD stock currently worth $42,316.



What does Ironwood Pharmaceuticals Inc do?

ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b



What does Ironwood Pharmaceuticals Inc's logo look like?

Ironwood Pharmaceuticals Inc logo

Complete history of Mark Currie stock trades at Ironwood Pharmaceuticals Inc e Cyclerion Therapeutics

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
11 Aug 2022 Mark G Currie
Vendita 70,000 $11.78 $824,600
11 Aug 2022
521,758
7 Jun 2022 Mark G Currie
Opzione 190,383 $11.65 $2,217,962
7 Jun 2022
782,141
14 Jun 2021 Mark G Currie
Vendita 23,571 $11.59 $273,188
14 Jun 2021
570,187
23 Jan 2020 Mark G Currie
Opzione 60,000 $9.12 $547,200
23 Jan 2020
609,272
16 Jan 2020 Mark G Currie
Opzione 8,888 $10.02 $89,058
16 Jan 2020
558,160
10 May 2019 Mark G Currie
Vendita 4,055 $10.53 $42,699
10 May 2019
528,903
7 Mar 2019 Mark G Currie
Vendita 275,000 $13.26 $3,646,500
7 Mar 2019
528,480
20 Feb 2019 Mark G Currie
Vendita 1,644 $14.31 $23,526
20 Feb 2019
803,480
4 Oct 2018 Mark G Currie
Opzione 233,301 $10.85 $2,531,316
4 Oct 2018
146,775
24 Aug 2018 Mark G Currie
Opzione 65,000 $4.95 $321,750
24 Aug 2018
840,000
22 Aug 2018 Mark G Currie
Opzione 130,000 $4.95 $643,500
22 Aug 2018
840,000
21 Feb 2018 Mark G Currie
Vendita 1,634 $14.66 $23,954
21 Feb 2018
18,124
24 Jan 2018 Mark G Currie
Opzione 60,000 $3.76 $225,600
24 Jan 2018
835,000
14 Mar 2017 Mark G Currie
Opzione 60,000 $3.76 $225,600
14 Mar 2017
835,000
22 Feb 2017 Mark G Currie
Vendita 1,800 $16.94 $30,492
22 Feb 2017
21,258
18 Jan 2017 Mark G Currie
Opzione 55,987 $2.94 $164,602
18 Jan 2017
775,000
6 Jan 2017 Mark G Currie
Opzione 34,013 $2.94 $99,998
6 Jan 2017
719,013
31 Oct 2016 Mark G Currie
Opzione 300,000 $2.94 $882,000
31 Oct 2016
685,000
9 Mar 2016 Mark G Currie
Opzione 160,898 $1.56 $251,001
9 Mar 2016
385,000
24 Feb 2016 Mark G Currie
Vendita 152,154 $8.53 $1,297,874
24 Feb 2016
374,102
4 Jan 2016 Mark G Currie
Opzione 64,102 $1.56 $99,999
4 Jan 2016
374,102
19 Feb 2015 Mark G Currie
Opzione 25,000 $0.60 $15,000
19 Feb 2015
335,000
13 Nov 2014 Mark G Currie
Opzione 20,000 $0.60 $12,000
13 Nov 2014
330,000
22 May 2014 Mark G Currie
Opzione 25,000 $0.60 $15,000
22 May 2014
335,000
24 Apr 2014 Mark G Currie
Opzione 25,000 $0.60 $15,000
24 Apr 2014
335,000
18 Feb 2014 Mark G Currie
Opzione 15,000 $0.60 $9,000
18 Feb 2014
325,000
23 Jan 2014 Mark G Currie
Opzione 20,000 $0.60 $12,000
23 Jan 2014
330,000
20 Feb 2013 Mark G Currie
Opzione 100,000 $0.60 $60,000
20 Feb 2013
310,000
21 Apr 2011 Mark G Currie
Opzione 20,000 $0.60 $12,000
21 Apr 2011
230,000
14 Apr 2011 Mark G Currie
Opzione 15,137 $0.60 $9,082
14 Apr 2011
225,137
11 Apr 2011 Mark G Currie
Opzione 24,863 $0.60 $14,918
11 Apr 2011
234,263
21 Mar 2011 Mark G Currie
Opzione 40,000 $0.60 $24,000
21 Mar 2011
250,000
3 Mar 2011 Mark G Currie
Opzione 7,721 $0.60 $4,633
3 Mar 2011
217,721
28 Dec 2020 Mark G Currie
Presidente e CSO
Vendita 20,107 $3.01 $60,522
28 Dec 2020
251,648
27 Dec 2019 Mark G Currie
Presidente e CSO
Vendita 50,000 $2.52 $126,000
27 Dec 2019
271,755
1 Apr 2019 Mark G Currie
Presidente e CSO
Acquistare 270,107 $14.81 $4,000,285
1 Apr 2019
321,755


Ironwood Pharmaceuticals Inc executives and stock owners

Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include: